Treatment of Postmenopausal Osteoporosis
- 21 March 2001
- journal article
- contempo updates
- Published by American Medical Association (AMA)
- Vol. 285 (11) , 1415-8
- https://doi.org/10.1001/jama.285.11.1415
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- The Effect of Low-Dose Continuous Estrogen and Progesterone Therapy With Calcium and Vitamin D on Bone in Elderly Women: A Randomized, Controlled TrialObstetrical & Gynecological Survey, 1999
- Prescribing Hormone Replacement Therapy for Menopausal SymptomsAnnals of Internal Medicine, 1999
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJAMA, 1999
- Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study GroupArchives of internal medicine (1960), 1997
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal OsteoporosisNew England Journal of Medicine, 1995
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- Treatment of Postmenopausal Osteoporosis with Transdermal EstrogenAnnals of Internal Medicine, 1992
- Age and bone mass as predictors of fracture in a prospective study.Journal of Clinical Investigation, 1988
- Postmenopausal Bone Loss Is Prevented by Treatment with Low-Dosage Estrogen with CalciumAnnals of Internal Medicine, 1987